Medicare Enrolled

Dr. Isabella Ilarda, MD

Dermatology · Middle Village, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
78-12 METROPOLITAN AVE, Middle Village, NY 11379
7184164600
In practice since 2006 (19 years)
NPI: 1982619318 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ilarda from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ilarda? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ilarda

Dr. Isabella Ilarda is a dermatology specialist in Middle Village, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ilarda performed 2,865 Medicare services across 1,750 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ilarda received a total of $4,451 from 34 pharmaceutical and/or device companies across 206 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ilarda is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 26% volume in NY $4,451 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,865
Medicare services
Top 26% in NY for dermatology
1,750
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~151 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
681 $78 $200
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
535 $109 $225
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
419 $87 $350
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
361 $48 $350
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
254 $6 $50
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
122 $50 $150
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
93 $88 $200
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
63 $1 $25
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
60 $159 $450
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
59 $55 $250
Destruction of cancerous skin growth on face, 0.6-1.0 cm
This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 0.6 and 1.0 centimeters in diameter.
42 $156 $450
Injection into skin growths, 1-7
A procedure involving the injection of medication into one to seven skin growths.
35 $48 $150
Simple drainage of skin abscess
A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing.
32 $114 $250
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
29 $142 $500
Injection into skin growths, more than 7
A procedure involving the injection of medication into more than seven skin growths.
27 $55 $250
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
23 $94 $350
Destruction of eyelid margin growth, 1.0 cm or less
This procedure involves the removal or destruction of a growth located on the margin of the eyelid that measures 1.0 centimeter or smaller.
18 $206 $500
Punch biopsy of first skin growth
A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination.
12 $121 $300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,451
Total received (2018-2024)
Avg $636/year across 7 years
Top 37% in NY for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
206
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,303 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$148 (3.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$593
2023
$585
2022
$415
2021
$253
2020
$497
2019
$1,042
2018
$1,065

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Arcutis Biotherapeutics, Inc.
$246
Dermavant Sciences, Inc.
$126
SUN PHARMACEUTICAL INDUSTRIES INC.
$91
MAYNE PHARMA COMMERCIAL LLC
$50
ABBVIE INC.
$33
Janssen Biotech, Inc.
$31
PFIZER INC.
$15
Top 3 companies account for 78.2% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$478
PFIZER INC.
$409
Arcutis Biotherapeutics, Inc.
$281
Encore Dermatology Inc.
$252
Sun Pharmaceutical Industries Inc.
$250
Galderma Laboratories, L.P.
$243
Promius Pharma LLC
$237
Regeneron Healthcare Solutions, Inc.
$231
EPI Health, LLC
$227
Ortho Dermatologics, a division of Bausch Health US, LLC
$167
Mayne Pharma Inc.
$166
Almirall LLC
$165
DERMIRA, INC.
$153
Dermavant Sciences, Inc.
$151
MAYNE PHARMA INC.
$137
ABBVIE INC.
$114
Lilly USA, LLC
$92
SUN PHARMACEUTICAL INDUSTRIES INC.
$91
GENZYME CORPORATION
$53
Incyte Corporation
$52
VYNE Pharmaceuticals Inc.
$51
Exeltis, USA Inc.
$51
MAYNE PHARMA COMMERCIAL LLC
$50
AbbVie Inc.
$50
AbbVie, Inc.
$43
Sandoz Inc.
$40
LEO Pharma Inc.
$40
Journey Medical Corporation
$36
Merck Sharp & Dohme Corporation
$32
PruGen, Inc. Pharmaceuticals
$30
Aclaris Therapeutics, Inc.
$22
Novum Pharma, LLC
$20
Taro Pharmaceuticals USA, Inc.
$20
Sebela Pharmaceuticals Inc.
$17
Top 3 companies account for 26.3% of all-time payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · AKLIEF · ALTRENO · AMZEEQ · APEXICON E · ARAZLO · Alcortin A · BRYHALI · Bensal HP · CIBINQO · CLODERM · Cloderm Cream · DORYX · DUOBRII · DUPIXENT · ELIDEL · EPSOLAY · EUCRISA · Exelderm · Humira · ILUMYA · Impoyz · LEXETTE · NAFTIN · Neocera · OLUMIANT · ONEXTON · OPZELURA · ORACEA · PICATO · QBREXZA · RHOFADE · RINVOQ · SIVEXTRO · SKYRIZI · SOLODYN · Sernivo · Sernivo Spray · Seysara · Sitavig · Skyrizi · TOPICORT (desoximetasone) Topical Spray · TREMFYA · TRIANEX 0.05% · Tremfya · VTAMA · Winlevi · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a dermatology specialist in Middle Village?
Compare dermatologists in the Middle Village area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
954
Per 100K population
40.9
County median income
$84,961
Nearest hospital
ELMHURST HOSPITAL CENTER
1.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ilarda is a clinical cardiology specialist, with above-average Medicare volume (top 26% in NY), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ilarda experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Ilarda performed 681 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ilarda receive payments from pharmaceutical companies?
Yes. Dr. Ilarda received a total of $4,451 from 34 companies across 206 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ilarda's costs compare to other dermatologists in Middle Village?
Dr. Ilarda's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ilarda) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →